Srividya Velagapudi

Schlieren, ZH, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Sirtuin-1 directly binds and deacetylates hepatic PCSK9 thereby promoting the inhibition of LDL receptor degradation.

Sirtuin-1 directly binds and deacetylates hepatic PCSK9 thereby promoting the inhibition of LDL receptor degradation.

Journal: Cardiovascular research

Published: January 27, 2025

Treatment with recombinant Sirt1 rewires the cardiac lipidome and rescues diabetes-related metabolic cardiomyopathy.

Treatment with recombinant Sirt1 rewires the cardiac lipidome and rescues diabetes-related metabolic cardiomyopathy.

Journal: Cardiovascular diabetology

Published: September 19, 2023

Inhibition of de novo ceramide synthesis by sirtuin-1 improves beta-cell function and glucose metabolism in type 2 diabetes.

Inhibition of de novo ceramide synthesis by sirtuin-1 improves beta-cell function and glucose metabolism in type 2 diabetes.

Journal: Cardiovascular research

Published: September 07, 2023

Chronic SIRT1 supplementation in diabetic mice improves endothelial function by suppressing oxidative stress.

Chronic SIRT1 supplementation in diabetic mice improves endothelial function by suppressing oxidative stress.

Journal: Cardiovascular research

Published: June 08, 2022

Posttranscriptional Regulation of the Human LDL Receptor by the U2-Spliceosome.

Posttranscriptional Regulation of the Human LDL Receptor by the U2-Spliceosome.

Journal: Circulation research

Published: November 23, 2021

Apolipoprotein M and Sphingosine-1-Phosphate Receptor 1 Promote the Transendothelial Transport of High-Density Lipoprotein.

Apolipoprotein M and Sphingosine-1-Phosphate Receptor 1 Promote the Transendothelial Transport of High-Density Lipoprotein.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: August 19, 2021

Sphingosine-1-phosphate receptor 3 regulates the transendothelial transport of high-density lipoproteins and low-density lipoproteins in opposite ways.

Sphingosine-1-phosphate receptor 3 regulates the transendothelial transport of high-density lipoproteins and low-density lipoproteins in opposite ways.

Journal: Cardiovascular research

Published: April 27, 2020

Macrophage NCOR1 protects from atherosclerosis by repressing a pro-atherogenic PPARγ signature.

Macrophage NCOR1 protects from atherosclerosis by repressing a pro-atherogenic PPARγ signature.

Journal: European heart journal

Published: April 11, 2019

Endocytosis of lipoproteins.

Endocytosis of lipoproteins.

Journal: Atherosclerosis

Published: March 16, 2018

Scavenger receptor BI promotes cytoplasmic accumulation of lipoproteins in clear-cell renal cell carcinoma.

Scavenger receptor BI promotes cytoplasmic accumulation of lipoproteins in clear-cell renal cell carcinoma.

Journal: Journal of lipid research

Published: January 05, 2018

Prevalence and causes of abnormal PSA recovery.

Prevalence and causes of abnormal PSA recovery.

Journal: Clinical chemistry and laboratory medicine

Published: March 21, 2017

VEGF-A Regulates Cellular Localization of SR-BI as Well as Transendothelial Transport of HDL but Not LDL.

VEGF-A Regulates Cellular Localization of SR-BI as Well as Transendothelial Transport of HDL but Not LDL.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: November 28, 2016

Showing 1-12 of 14

Last Updated: 09/26/2026